SPOTLIGHT: Allergan to pay $370M for Esprit Pharma


Allergan has inked a deal to buy privately held Esprit Pharma, which specializes in genitourinary treatments, for $370 million. Esprit currently markets Sanctura, a remedy for overactive bladder, and has applied for FDA approval for an extended release form of that drug. Release